Ref.: BL-RE-143693Manufacturer ref.: EH460RBX5 5 x 96 tests
€2,950.00 excl. VAT
Human TLR-4 quantitates human TLR-4 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human TLR-4.
Accession number
ARMD10 ; CD284 ; EGK_07381 ; homologue du Toll drosophile ; hToll ; réponse lipopolysaccharidique ; Lps ; Ly87 ; Ran/M1 ; Rasl2-8 ; Tlr4 ; TLR-4 ; TOLL ; Récepteur 4 de type Toll ; domaine des récepteurs de type Toll/interleukine-l (TIR) ; toll4 ; récepteur 4 de type Toll ; protéine liée à l’immunité du récepteur 4 de type Toll ; protéine similaire au récepteur 4 de type Toll ; protéine de récepteur 4 de type Toll
Dose range
0.4 to 100 ng/ml
Sensitivity of the dosage
0.4 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen
Human TLR-4 quantitates human TLR-4 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human TLR-4.
Human TLR-4 quantitates human TLR-4 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human TLR-4.
TLR4 is part of the Toll-type receptor family (TLR) that plays a fundamental role in the recognition of pathogens and the activation of innate immunity. LRTs are highly conserved from the Drosophile to humans and share structural and functional similarities. This receptor is expressed in abundance in the placenta and myelomocytic subpopulation of leukocytes. Mammal cells react to LPS by activating TLR4. TLR4 is part of the lipopolysaccharide receptor (LPS) multiprotein complex containing CD14, LY96, and TLR4, and is involved in the lipopolysaccharide (LPS)-induced signal transduction events found in most Gram-negative bacteria. TLR4 facilitates the recognition of pathogenic-associated molecular profiles (PAMPs) that are expressed on infectious agents and mediate the production of cytokines necessary for the development of effective immunity. The various LRTs have different modes of expression. TLR4 mutations were associated with differences in LPS reactivity. Several variants of transcription of the TLR4 gene were found, but the coding potential of most proteins is uncertain. TLR4 is expressed by peripheral blood monocytes and a small population of B cells and is also expressed in the human placenta. Studies with mice with LRT4 deficiency indicate that the primary LRT ligand is lipopolysaccharide. Therefore, these mice also showed increased sensitivity to Gram-negative septicemia.